12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·04/01/2026 12:05:41
Listen to the news
Gainers
Cyclerion Therapeutics (NASDAQ:CYCN) stock moved upwards by 140.0% to $3.72 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.8 million.
bioAffinity Technologies (NASDAQ:BIAF) stock rose 13.83% to $4.36. The market value of their outstanding shares is at $17.2 million.
Ascentage Pharma Group (NASDAQ:AAPG) stock rose 9.59% to $26.16. The market value of their outstanding shares is at $2.2 billion.
Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 9.12% to $2.32. The market value of their outstanding shares is at $3.6 million.
Kala Bio (NASDAQ:KALA) shares increased by 8.72% to $0.19. The market value of their outstanding shares is at $157.7 million.
Axe Compute (NASDAQ:AGPU) shares increased by 8.02% to $1.75. The company's market cap stands at $5.4 million. The company's, Q4 earnings came out yesterday.
Losers
ORIC Pharmaceuticals (NASDAQ:ORIC) shares fell 21.5% to $9.95 during Wednesday's pre-market session. The company's market cap stands at $1.4 billion.
Passage Bio (NASDAQ:PASG) stock declined by 20.77% to $6.22. The company's market cap stands at $24.9 million.
IO Biotech (NASDAQ:IOBT) stock declined by 19.09% to $0.05. The market value of their outstanding shares is at $4.2 million.
BioAtla (NASDAQ:BCAB) shares decreased by 16.15% to $0.14. The market value of their outstanding shares is at $13.3 million. The company's, Q4 earnings came out yesterday.
Dogwood Therapeutics (NASDAQ:DWTX) shares fell 14.7% to $1.8. The company's market cap stands at $70.4 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.